Loading...

SCSP

SPRC

SCISPARC LTD

(SPRC)

2025 6-K

Patent Collaboration

16 Mar '26

Acquisition Announcement

12 Mar '26

Share Split Announcement

2 Mar '26

Funding Update

17 Feb '26

Funding Agreement

12 Feb '26

Shareholder Approval

4 Feb '26

Patent Granted

2 Feb '26

IP Acquisition Completed

26 Jan '26

New Share Offering

13 Jan '26

Patent Acquisition

13 Jan '26

Stockholder Equity Alert

12 Jan '26

Accounting Firm Change

31 Dec '25

Stake Acquisition

2 Dec '25

Securities Purchase Agreement

28 Nov '25

Patent Acquisition

26 Nov '25

Patent Announcement

20 Nov '25

Financial Report

18 Nov '25

Company Acquisition

27 Oct '25

Subsidiary Sale Closed

24 Oct '25

Asset Acquisition

15 Oct '25

Framework Agreement Update

6 Oct '25

Merger Announcement

30 Sep '25

Warrant Exercise Agreement

26 Sep '25

Management Changes

25 Sep '25

Merger Update

16 Sep '25

Investigation Update

8 Sep '25

Conversion of Debentures

29 Aug '25

Merger Approval

28 Aug '25

Shareholder Meeting Approved

26 Aug '25

Meeting Adjourned

25 Aug '25

Patent Collaboration

8 Aug '25

Merger Update

31 Jul '25

Share Split Report

22 Jul '25

Compliance Regained

22 Jul '25

Shareholder Approval

26 Jun '25

Annual Meeting Update

25 Jun '25

Share Split Announced

24 Jun '25

Merger Agreement Update

9 Jun '25

Patent Application Filed

27 May '25

Annual Meeting Notice

21 May '25

Patent Announcement

13 May '25

Patent Application Filed

25 Apr '25

Spin-Off Update

1 Apr '25

Merger Update

1 Apr '25

Patent Publication Update

11 Mar '25

Sale Agreement

3 Mar '25

Securities Deal

27 Feb '25

Legal Settlement Secured

18 Feb '25

Patent Announcement

4 Feb '25

Nasdaq Extension Granted

15 Jan '25

Patent Publication Announce...

7 Jan '25

Approval Renewal

31 Dec '24

Vehicle Delivery Announcement

26 Dec '24

Spin-off Update

17 Dec '24

Merger Announcement

29 Nov '24

Merger Agreement Update

27 Nov '24

Financial Report

4 Nov '24

Shareholder Approval

23 Oct '24

Annual Meeting Update

22 Oct '24

Meeting Postponed

27 Sep '24

Stake Sale Intent

26 Sep '24

FDA Approval Announcement

23 Sep '24

Patent Collaboration

16 Sep '24

Loan Amendment

11 Sep '24

SciSparc Patent News

6 Sep '24

Collaboration Announcement

29 Aug '24

FDA Application Filed

26 Aug '24

Annual Meeting Notice

22 Aug '24

Clinical Trial Update

20 Aug '24

Patent License Agreement

19 Aug '24

Merger Update

14 Aug '24

Merger Approval Update

13 Aug '24

New Drug Potential

6 Aug '24

Cancer Drug Update

23 Jul '24

Licensing Agreement

17 Jul '24

Nasdaq Notification

16 Jul '24

Patent Announcement

16 Jul '24

Spin-off Announcement

8 Jul '24

Loan Agreement Update

14 Jun '24

Patent Grant News

3 Jun '24

Merger Announcement

2 May '24

Merger Announcement

11 Apr '24

Patent Collaboration News

27 Mar '24

Clinical Trial Milestone

15 Mar '24

MitoCareX Update

13 Mar '24

New Patents Announced

8 Mar '24

New Clinical Trial

29 Feb '24

Patent Applications Filed

27 Feb '24

Patent Portfolio Update

20 Feb '24

License Termination Alert

12 Feb '24

Clinical Trial Launch

29 Jan '24

Equity Purchase Agreement

25 Jan '24

Acquisition Process

22 Jan '24

External Links:

SEC

On October 20, 2025, SciSparc Ltd. finalized the sale of its majority-owned subsidiary MitoCareX to N2OFF, Inc. for $700,000 cash and 490,751 shares representing 16.75% of N2OFF's common stock.

AI Assistant

SCISPARC LTD

2025

6 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.